These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34899321)

  • 41. 3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors.
    Wang Y; Jia S; Wang F; Jiang R; Yin X; Wang S; Jin R; Guo H; Tang Y; Wang Y
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors.
    Ashraf N; Asari A; Yousaf N; Ahmad M; Ahmed M; Faisal A; Saleem M; Muddassar M
    Front Chem; 2022; 10():1003816. PubMed ID: 36405310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D-QSAR, molecular docking, and molecular dynamics simulation of a novel thieno[3,4-d]pyrimidine inhibitor targeting human immunodeficiency virus type 1 reverse transcriptase.
    Chu H; He QX; Wang JW; Deng YT; Wang J; Hu Y; Wang YQ; Lin ZH
    J Biomol Struct Dyn; 2020 Sep; 38(15):4567-4578. PubMed ID: 31760877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular modeling studies of benzothiophene-containing derivatives as promising selective estrogen receptor downregulators: a combination of 3D-QSAR, molecular docking and molecular dynamics simulations.
    Zhang C; Li Q; Ren Y; Liu F
    J Biomol Struct Dyn; 2021 May; 39(8):2702-2723. PubMed ID: 32249694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.
    Mao Y; Li Y; Hao M; Zhang S; Ai C
    J Mol Model; 2012 May; 18(5):2185-98. PubMed ID: 21947448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
    Itteboina R; Ballu S; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics.
    Wang F; Li Y; Ma Z; Wang X; Wang Y
    J Mol Model; 2012 Jan; 18(1):295-306. PubMed ID: 21523548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
    Zeng H; Zhang H; Jang F; Zhao L; Zhang J
    Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1).
    Xu QX; Guo L; Li Y; Wang ZW; Hu P; Yang GM; Pan Y
    J Biomol Struct Dyn; 2023 Sep; ():1-18. PubMed ID: 37668086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
    Balasubramanian PK; Balupuri A; Bhujbal SP; Cho SJ
    J Biomol Struct Dyn; 2019 May; 37(8):2165-2178. PubMed ID: 30044205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer.
    Er-Rajy M; El Fadili M; Imtara H; Saeed A; Ur Rehman A; Zarougui S; Abdullah SA; Alahdab A; Parvez MK; Elhallaoui M
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang Z; Cheng L; Kai Z; Wu F; Liu Z; Cai M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3869-76. PubMed ID: 25022881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Modeling Studies of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors through Receptor-Based 3D-QSAR and Molecular Dynamics Simulations.
    Qian H; Chen J; Pan Y; Chen J
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27657020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.